Disease / condition

Onychomycosis clinical trials

Free access to 103 studies·10+ countries·Updated daily12 recruiting
103
Total trials
10+
Countries
10+
Sponsors
12
Recruiting
By phase
N/A31
Phase 228
Phase 316
Phase 111
Early Phase 17
By status
Completed68
Unknown14
Not yet recruit...12
Recruiting4
Terminated2
Top countries
United States of America38
China7
Japan4
Mexico3
Canada,United States of America3
Top sponsors
Pfizer6
Erchonia Corporati...4
Moberg Pharma AB4
Stiefel, a GSK Com...4
Polichem S.A.3
Recent trials
Latest clinical trials for Onychomycosis
NCT06327295·Phase 2Not yet recr...
A Study of ATB1651 in Adults With Mild to Moderate Onchomycosis
AmtixBio Co., Ltd.New Zealand
NCT06254027Not yet recr...
Clinical Investigation for the Evaluation of Efficacy and Safety of Two Medical Devices for Onychomycosis Treatment
Oystershell NV
NCT05809297·Phase 4Not yet recr...
Diode Laser and Photodynamic Therapy Vs. Ciclopirox.
Universidad Complutense de Mad...
2022-003913-12Ongoing
Diode laser and photodynamic therapy Versus Ciclopirox Hydroxypropyl Chitosan. Randomised controlled clinical trial.
COMPLUTENSE UNIVERSITY OF MADR...
UMIN000050195Not yet recr...
A questionnaire survey of physicians and patients on onychomycosis treatment
OtherJapan
NCT05626270Completed
Human Factors Testing for OTC Use of the Erchonia® LunulaLaser
Erchonia CorporationUnited States of America
NCT05578950·Phase 1Completed
Comparative Study Between Pulse Therapy With Oral Itraconazole Versus Continuous Oral Terbinafine Therapy for Treatment of Onychomycosis
Combined Military Hospital Abb...Pakistan
NCT05560841Recruiting
Effectiveness and Safety of Nailner Brush 2in1 in Onychomycosis
Karo Pharma ABTunisia
NCT05491603·Phase 2Suspended
A Trial to Evaluate the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With Onychomycosis
DermBiont, Inc.United States of America
UMIN000048054·Not ApplicableRecruiting
In real-world clinical practice current status of refractory with topical antifungal drug therapy on onychomycosis and efficacy and safety of fosravuconazole switching treatment: a retrospective study
Sato Pharmaceutical Co., LtdJapan
NCT05390190Not yet recr...
Radiofrequency in Onychomycosis
Cairo University
NCT05415852Not yet recr...
Lasers in Onychomycosis
Cairo University
NCT05279846·Phase 3Recruiting
A Vehicle-controlled Study of Topical MOB015B in the Treatment of Distal Subungual Onychomycosis (DSO)
Moberg Pharma ABUnited States of America
UMIN000045924·Not ApplicableCompleted
Efficacy and safety of fosravuconazole for the treatment of onychomycosis: A multicenter, retrospective study
Sato Pharmaceutical Co.,LtdJapan
NCT05089409·Phase 1Not yet recr...
A Study of ATB1651 in Adults With Mild to Moderate Onychomycosis
AmtixBio Co., Ltd.
ChiCTR2100050376·Early Phase 1Not yet recr...
Untitled Trial
Shanghai Skin Disease HospitalChina
NCT04940520·Phase 1Completed
Alpha-bisabolol for Onychomycosis Treatment
Universidade do Vale do Sapuca...Brazil
ChiCTR2100046586·Early Phase 1Not yet recr...
Untitled Trial
Shanghai Skin Disease HospitalChina
ChiCTR2000037753·Early Phase 1Not yet recr...
Untitled Trial
Shanghai Skin Disease HospitalChina
jRCTs031200047Completed
Untitled Trial
About this record

Access comprehensive clinical trial information for Onychomycosis through Pure Global AI's free database. This collection includes 103 clinical trials across multiple phases including N/A, Phase 2, Phase 3. Currently, 12 trials are actively recruiting participants.

Research for Onychomycosis is being conducted in United States of America, China, Japan and 7+ other countries. Leading sponsors include Pfizer and Erchonia Corporation. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 103 clinical trials studying Onychomycosis, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include Pfizer, Erchonia Corporation, Moberg Pharma AB, among others.